Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMITAPIDE vs LOPERAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOMITAPIDE vs LOPERAMIDE: Safety Overview

Metric LOMITAPIDE LOPERAMIDE
Total FAERS Reports 3,779 18,011
Deaths Reported 109 1,551
Death Rate 2.9% 8.6%
Hospitalizations 434 4,298
Average Patient Age 54.6 yrs 58.9 yrs
% Female Patients 66.5% 64.3%
FDA Approval Date Apr 23, 2015 Approved Prior to Jan 1, 1982
Manufacturer Amryt Pharmaceuticals DAC Chain Drug Consortium
Route ORAL ORAL
Marketing Status Prescription Discontinued